<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Dalsgaard | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/nerveunit55/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/nerveunit55/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Dalsgaard.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">bb37f01d564f83ebc7b6960ffa579287</guid>
				<title>Dalsgaard posted an update: Risk models, informing optimal long-term medical management, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41768/</link>
				<pubDate>Sat, 08 Feb 2025 10:48:03 -0800</pubDate>

									<content:encoded><![CDATA[<p>Risk models, informing optimal long-term medical management, seldom use natriuretic peptides (NP) in ascertaining the absolute risk of outcomes for HF patients. Individual studies evaluating the prognostic value of NPs in HF patients have reported varying effects, arriving at best estimates requires a systematic review. We systematically&hellip;<span class="activity-read-more" id="activity-read-more-41768"><a href="http://www.nationalboardinstitute.com/activity/p/41768/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">949d09f6714884eefe9e2adfb700b316</guid>
				<title>Dalsgaard posted an update: The composite with 15 phr CCB presents an [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40072/</link>
				<pubDate>Thu, 06 Feb 2025 12:52:47 -0800</pubDate>

									<content:encoded><![CDATA[<p>The composite with 15 phr CCB presents an absorption-dominated electromagnetic interference shielding effectiveness (EMI SE) as high as 27.29 dB at the X-band. The composite also presents higher tribological properties, mechanical properties, and thermal stability compared to the UP blend. This effort provides a simple and effective way for the&hellip;<span class="activity-read-more" id="activity-read-more-40072"><a href="http://www.nationalboardinstitute.com/activity/p/40072/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b79003eb7d79c7d2d46c890ea96694b0</guid>
				<title>Dalsgaard posted an update: Grief is understandably severe in the first days, if not [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38379/</link>
				<pubDate>Tue, 04 Feb 2025 11:17:16 -0800</pubDate>

									<content:encoded><![CDATA[<p>Grief is understandably severe in the first days, if not weeks or months, following the death of a beloved person. Unless the mourner develops complicated grief, which is prolonged severe and impactful grief, the initial acute grief lessens in severity over time, although waves of significant grief will still occur with grief triggers. A scoping&hellip;<span class="activity-read-more" id="activity-read-more-38379"><a href="http://www.nationalboardinstitute.com/activity/p/38379/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">00f7944b0f56107a6e1b7a5211bc0997</guid>
				<title>Dalsgaard posted an update: A cross-study subjective outcome synthesis revealed [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36527/</link>
				<pubDate>Sun, 02 Feb 2025 10:57:07 -0800</pubDate>

									<content:encoded><![CDATA[<p>A cross-study subjective outcome synthesis revealed low-fidelity arthroscopic simulators reduced time to completion outcomes (2 studies, P &lt; .05), increased Arthroscopic Surgical Skill Evaluation Tool scores (2 studies, P &lt; .01), and confirmed face validity (2 studies) and transfer of skills to cadavers (2 studies) or live patients (1 study). Cost&hellip;<span class="activity-read-more" id="activity-read-more-36527"><a href="http://www.nationalboardinstitute.com/activity/p/36527/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">026c7d6e5b1fb9a0ea21c1f2dbf37990</guid>
				<title>Dalsgaard posted an update: Circular RNA circ_0136474 is a new contributor of human [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34761/</link>
				<pubDate>Fri, 31 Jan 2025 11:18:21 -0800</pubDate>

									<content:encoded><![CDATA[<p>Circular RNA circ_0136474 is a new contributor of human osteoarthritis (OA) by suppressing chondrocyte proliferation. However, its role and mechanism in OA chondrocyte injury remain ill defined. Herein, we performed real-time quantitative PCR to detect RNA expression of circ_0136474, microRNA (miR)-766-3p, and DNA methyltransferase 3A (DNMT3A) and&hellip;<span class="activity-read-more" id="activity-read-more-34761"><a href="http://www.nationalboardinstitute.com/activity/p/34761/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">cd7feb2f77563a763b03ca4fc89db54f</guid>
				<title>Dalsgaard posted an update: In the exploratory Study 1 (N = 20), we developed and tes [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33950/</link>
				<pubDate>Thu, 30 Jan 2025 11:25:24 -0800</pubDate>

									<content:encoded><![CDATA[<p>In the exploratory Study 1 (N = 20), we developed and tested a preliminary version of the CPICB that had 480 items. After selecting 400 items that yielded the most consistent responses, we carried out a confirmatory test-retest Study 2 (N = 40). Preregistered data analyses confirmed excellent construct validity, internal consistency and test-re&hellip;<span class="activity-read-more" id="activity-read-more-33950"><a href="http://www.nationalboardinstitute.com/activity/p/33950/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">482221fedb484cc1b1470dc08bc6e310</guid>
				<title>Dalsgaard posted an update: The MSSI scores in the patients were correlated with serum [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30165/</link>
				<pubDate>Tue, 28 Jan 2025 14:50:45 -0800</pubDate>

									<content:encoded><![CDATA[<p>The MSSI scores in the patients were correlated with serum levels of IL-6 (r=0.60, p&lt;0.001) and TNF-α (r=0.45, p&lt;0.001).</p>
<p> FD was associated with elevated serum levels of IL-6 and TNF-α in this cohort. The FD patients treated with ERT, particularly, women, exhibited higher levels of serum IL-6 and TNF-α than those not treated with ERT; th&hellip;<span class="activity-read-more" id="activity-read-more-30165"><a href="http://www.nationalboardinstitute.com/activity/p/30165/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>